Erectile Dysfunction Therapeutic Pipeline Review H2 2015 Market Research Report at RnRMarketResearch.com
Dallas, TX (PRWEB) January 26, 2015 -- The report "Erectile Dysfunction – Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Erectile Dysfunction. Erectile dysfunction is the failure to get or keep an erection firm enough to have sexual intercourse. However, frequent Erectile dysfunction can be a sign of health problems that need treatment. Erectile dysfunction can have severe mental consequences as it can be joined to relationship difficulties and masculine self-image generally. Research indicates that approximately 40% of males suffer from erectile dysfunction. Complete report is available at http://www.rnrmarketresearch.com/erectile-dysfunction-pipeline-review-h1-2015-market-report.html .
It also reviews key players involved in the therapeutic development for Erectile Dysfunction and special features on late-stage and discontinued projects. Companies discussed in this Erectile Dysfunction Pipeline Review H1 2015 report include Acorda Therapeutics, Inc., Apricus Biosciences, Inc., Aprogen, Inc., Bioheart, Inc., Biolab Sanus Farmaceutica Ltda., Corridor Pharmaceuticals Inc., Furiex Pharmaceuticals, Inc., Futura Medical plc, Hanmi Pharmaceuticals, Co. Ltd., IntelGenx Corp., Mezzion Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, NAL Pharmaceuticals Ltd., Pacific Therapeutics Ltd., Palatin Technologies, Inc., Pharmicell Co., Ltd., Sagene Pharmaceuticals, Inc., Suda Ltd, Yungjin Pharm Ind. Co., Ltd.
The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=269553 . (This is a premium report priced at US$2000 for a single user License.)
Table of Contents
List of Tables
Number of Products under Development for Erectile Dysfunction, H1 2015 10
Number of Products under Development for Erectile Dysfunction - Comparative Analysis, H1 2015 11
Number of Products under Development by Companies, H1 2015 13
Number of Products under Investigation by Universities/Institutes, H1 2015 14
Comparative Analysis by Late Stage Development, H1 2015 15
Comparative Analysis by Clinical Stage Development, H1 2015 16
Comparative Analysis by Early Stage Development, H1 2015 17
Comparative Analysis by Unknown Stage Development, H1 2015 18
Products under Development by Companies, H1 2015 19
Products under Development by Companies, H1 2015 (Contd..1) 20
Products under Investigation by Universities/Institutes, H1 2015 21
Erectile Dysfunction - Pipeline by Acorda Therapeutics, Inc., H1 2015 22
Erectile Dysfunction - Pipeline by Apricus Biosciences, Inc., H1 2015 23
Erectile Dysfunction - Pipeline by Aprogen, Inc., H1 2015 24
Erectile Dysfunction - Pipeline by Bioheart, Inc., H1 2015 25
Erectile Dysfunction - Pipeline by Biolab Sanus Farmaceutica Ltda., H1 2015 26
Erectile Dysfunction - Pipeline by Corridor Pharmaceuticals Inc., H1 2015 27
Erectile Dysfunction - Pipeline by Furiex Pharmaceuticals, Inc., H1 2015 28
Erectile Dysfunction - Pipeline by Futura Medical plc, H1 2015 29
Erectile Dysfunction - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015 30
Erectile Dysfunction - Pipeline by IntelGenx Corp., H1 2015 31
Erectile Dysfunction - Pipeline by Mezzion Pharma Co. Ltd., H1 2015 32
Erectile Dysfunction - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015 33
Erectile Dysfunction - Pipeline by NAL Pharmaceuticals Ltd., H1 2015 34
Erectile Dysfunction - Pipeline by Pacific Therapeutics Ltd., H1 2015 35
Erectile Dysfunction - Pipeline by Palatin Technologies, Inc., H1 2015 36
Erectile Dysfunction - Pipeline by Pharmicell Co., Ltd., H1 2015 37
Erectile Dysfunction - Pipeline by Sagene Pharmaceuticals, Inc., H1 2015 38
Erectile Dysfunction - Pipeline by Suda Ltd, H1 2015 39
Erectile Dysfunction - Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2015 40
Assessment by Monotherapy Products, H1 2015 41
Assessment by Combination Products, H1 2015 42
Number of Products by Stage and Target, H1 2015 44
Number of Products by Stage and Mechanism of Action, H1 2015 46
Number of Products by Stage and Route of Administration, H1 2015 48
Number of Products by Stage and Molecule Type, H1 2015 50
Erectile Dysfunction Therapeutics - Recent Pipeline Updates, H1 2015 83
Erectile Dysfunction - Dormant Projects, H1 2015 94
Erectile Dysfunction - Dormant Projects (Contd..1), H1 2015 95
Erectile Dysfunction - Dormant Projects (Contd..2), H1 2015 96
Erectile Dysfunction - Discontinued Products, H1 2015 97
Explore more reports on Men's Health therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/mens-health-therapeutics .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Ritesh Tiwari, RnRMarketResearch, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]
Share this article